Wegovy and changes to neck skin: separating myth from fact

The misconception: that semaglutide attacks skin around the neck

A phrase circulating online suggests that GLP-1 medicines somehow target or damage skin, particularly around the neck and jawline. That is not how semaglutide works. Wegovy acts on GLP-1 receptors involved in appetite signalling and glucose regulation — it does not have a known direct mechanism on dermal collagen, elastin or subcutaneous tissue in a way that would selectively thin neck skin. The NHS patient information for semaglutide lists recognised side effects, and skin thinning around the neck is not among them.

What does happen is weight loss, often substantial. In the STEP 1 trial, participants lost an average of around 15% of body weight over 68 weeks at the 2.4mg maintenance dose. Losing a significant amount of body fat (anywhere on the body) can leave skin that had previously been supported by underlying fat with less volume beneath it. The neck and face are areas where many people notice this first, simply because the skin there is relatively thin and any change in the fat layer beneath it is visible. That is a consequence of the weight loss itself, not of semaglutide chemistry.

If you have noticed changes around your neck area and are uncertain whether they are related to treatment, a conversation with your prescriber is the right starting point. You can also read more about how Wegovy affects skin more broadly beyond the neck.

What is actually causing the neck skin changes people report

Three mechanisms account for most of what people describe. First, and most commonly, it is skin laxity following volume reduction, the fat beneath the chin and along the neck shrinks, and skin that stretched over a larger area does not always retract at the same rate. This is a normal biological response to significant weight loss by any means, including diet and bariatric surgery. Skin elasticity is partly genetic and partly influenced by age, sun exposure history and the speed of weight loss.

Second, some people reduce their overall food intake substantially while on Wegovy, particularly protein. Semaglutide suppresses appetite effectively, and without conscious effort to maintain adequate protein consumption, lean tissue and skin quality can both suffer. Protein provides the amino acids needed for collagen synthesis. A prescriber or dietitian can advise on protein targets while on treatment.

Third, a small number of people report injecting in non-licensed sites, including the neck area. The licensed injection sites for Wegovy are the abdomen, thigh and upper arm. Injecting outside those sites is not recommended; any localised skin reaction in an unlicensed area should be discussed with your prescriber. For a broader look at semaglutide and skin-related questions, that page covers the full picture.

It is also worth keeping your pen stored correctly, because it matters more than people expect, the active medicine in the pen degrades if left out of the fridge for longer than the patient information leaflet allows.

What you can do about it, and what the limits are

There is no clinically proven way to prevent all skin laxity from weight loss, but there are practical steps that evidence suggests can help. Maintaining adequate protein intake is top of the list. Resistance exercise helps preserve lean muscle mass, which keeps skin better supported from underneath. Hydration matters too, since dehydrated skin shows laxity more readily.

Pacing matters as well. Rapid weight loss tends to produce more pronounced laxity than gradual loss, though for many people on Wegovy the clinical benefits of treatment outweigh this cosmetic concern. That is an individual conversation to have with a prescriber who knows your full health picture. Our clinical team reviews every patient's case personally before and during treatment.

Some people pursue non-invasive skin tightening treatments (radiofrequency, ultrasound devices) after significant weight loss; evidence for these is mixed and they sit outside the scope of weight management prescribing. For those specifically concerned about the neck and jaw area, the pages on Wegovy and neck changes and neck stiffness reported with Wegovy cover the related questions people most often ask.

Wegovy remains a prescription-only medicine and any skin concern that develops or worsens during treatment deserves a proper clinical review rather than a self-managed workaround. If you're considering starting treatment and want to understand how it fits your situation, the weight loss treatment overview is a useful place to begin. You can also explore what a consultation involves on the treatment page, our prescribers can discuss skin-related concerns as part of the initial review. For a fuller look at semaglutide as a medicine, including how it is titrated and what to expect at each stage, that page has the detail.